Dextrose Injection
Product Images NDC 0338-0204

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Dextrose (NDC 0338-0204). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Assembly 1 (Image 01)

An instructional diagram illustrating the assembly step for a drug vial. The image labels parts of the vial including the vial cover, closure, and drug vial, and shows measurements of 13 mm or 20 mm for the vial cover. Instructions on the side state to remove the vial cover and disinfect the stopper.*

FDA Label Image

Assembly 2 (Image 02)

An instructional diagram showing a Mini-Bag Plus Container used for intravenous injection. The illustration labels the Bag, Breakaway Seal inside the port tube, Drug Vial Adaptor, and Administration Part. Instructions on the right advise peeling off the foil cover, inspecting the adaptor for moisture, and discarding it if moisture is found.*

FDA Label Image

Assembly 3 (Image 03)

An instructional illustration showing how to connect an adaptor to a vial by holding the vial upright and pushing the adaptor down until it snaps in place, with accompanying text emphasizing not to twist the vial. This step is part of preparing Dextrose injection for intravenous use.*

FDA Label Image

Reconstitution 4 (Image 04)

An instructional diagram labeled 'Reconstitution' showing hands squeezing a bag and checking a vial. Additional illustrations depict how to break the vial seal by bending back and forth until a clear gap appears, with accompanying steps listed as bullet points.*

FDA Label Image

Reconstitution 5 (Image 05)

An instructional diagram depicting a hand holding an intravenous fluid bag connected to a small vial below. The steps advise for powdered drug vials to hold the bag with the vial down, squeeze the solution into the vial until half full, and shake to suspend the drug. For liquid drug vials, proceed directly to the next step.*

FDA Label Image

Reconstituion 6 (Image 06)

An instructional diagram illustrating how to mix a drug vial with a flexible bag. It shows hands holding the bag and vial, with steps directing to hold the bag with the vial upside down, squeeze the bag to force air into the vial, release to drain the drug into the bag, and repeat to ensure the drug is completely dissolved without removing the drug vial.*

FDA Label Image

D-glucose Monohydrate Chemical Structure (Image 07)

Chemical structure of Dextrose Hydrous, USP (Dextrose Monohydrate) showing the molecular arrangement including hydroxyl groups and a water molecule of hydration.*

FDA Label Image

Representative Container Lbl 0338-0204-04 (Image 08)

Label for 5% Dextrose Injection USP in a 50 mL MINI-BAG PLUS container by Baxter Healthcare Corporation. The label indicates it contains 2.5 g Dextrose Hydrous per 50 mL, for intravenous use with a 13 mm vial. It is sterile, nonpyrogenic, with osmolarity 252 mOsmol/L and pH range 3.2 to 6.5. Instructions include breaking the seal and mixing before use, and cautions about dosage and simultaneous use with blood products.*

FDA Label Image

Representative Container Lbl 0338-0211-04 (Image 09)

Label for 5% Dextrose Injection USP, 50 mL vial by Baxter Healthcare Corporation. Each 50 mL contains 2.5 g dextrose monohydrate in sterile, nonpyrogenic solution with pH 4.0 and osmolarity 252 mOsmol/L. The label includes usage instructions, cautions, and vial specifications (20 mm vial size, single-dose container). It is for intravenous use only.*

FDA Label Image

Representative Container 0338-0208-04 (Image 10)

Label for 5% Dextrose Injection USP in a 100 mL Mini-Bag Plus container designed for intravenous use with a 13mm vial. The label indicates each 100 mL contains 5 g of dextrose monohydrate with a pH of 4.0 and osmolality of 252 mOsmol/L. It is a sterile, nonpyrogenic single-dose container manufactured by Baxter Healthcare Corporation in Deerfield, IL, USA. The label includes instructions to break seal and mix before use.*

FDA Label Image

Representative Container Lbl 0338-0216-04 (Image 11)

Label for 5% Dextrose Injection USP in a 100 mL MINI-BAG PLUS Container by Baxter Healthcare Corporation. The label indicates the product contains 5 g dextrose per 100 mL with pH 4.0 and osmolarity 252 mOsmol/L. It is nonpyrogenic, single dose, intravenous injection for use with a 20 mm vial. The container is made by Baxter Healthcare Corporation, Deerfield, IL, USA. Instructions indicate to break seal and mix before use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.